Marked against last year's 10-K:
cut words struck through, new words highlighted and underlined.
Risk Factors 214 words changed in this paragraph; it is 30% similar to last year's version.
Our business is global, so and changes to existing international trade agreements, blocking of foreign trade, increased protectionism, or imposition of tariffs on foreign goods could could, among other things, weaken consumer confidence, negatively impact employment rates in industries on which we are dependent, result in decreased revenues and/or increases higher cost of goods sold and lower gross profit and margins, cause supply chain delays or disruptions or diminishing returns on capital investments, including with respect to our ongoing distribution center optimization initiative, and deter customers in pricing, either our Industrial segment from pursuing facilities and automation projects, all of which could have an adverse impact on our business, results of operations, financial condition and cash flows in future periods. For instance, the United States imposed Section 232 tariffs on many imported products of steel and aluminum in March 2018 and expanded the tariffs to additional derivative products of steel and aluminum effective February 8, 2020. The United States imposed Section 301 tariffs on most imported products from China starting in July 2018. Although the United States and China reached a Phase One trade deal in January 2020, there was no Phase Two trade deal implemented and most of the tariffs imposed remain in place. Uncertainty persists in the trade relationship between the two countries that impacts the global trade landscape, and as of February 2025, new tariffs were enacted that significantly increase tariffs on foreign imports into the United States. The effects of these changes, including responsive actions from foreign governments, could also have significant impacts on our financial results.
Source: Item 1A, 10-K 0000040987-26-000003 vs Item 1A, 10-K 0000040987-25-000026
MD&A 190 words changed in this paragraph; it is 34% similar to last year's version.
SG&A expenses increased $476 $508 million, or 7.7%, 7.6%, from 2023. Approximately 50% 2024. The growth in SG&A expenses was largely attributable to elevated operating expenses linked to acquisitions of the approximately $225 million and a $103 million increase in our asbestos-related product liability due to adverse trends in claim counts and costs. The remaining increase was driven by personnel expense inflationary wage pressures, rising healthcare costs and 10% by higher rent expense, reflecting inflationary pressures on annual wage increases and lease renewals and higher operating costs expense due to acquisitions, primarily from the addition of more U.S. automotive stores. Additionally, 10% of the increase was attributable lease renewals. We also continue to our make investments in technology as we continue to enhance our supply chain and digital capabilities to as we improve the customer experience, increase automation in distribution centers, and modernize payment platforms. The remainder of the increase was attributable to other SG&A categories, as we incurred higher operating costs from acquired businesses, and we continued to invest in our supply chain to optimize product assortment and positioning, which helps reduce distribution costs. Partially offsetting these increases was approximately $175 million of cost savings associated with our global restructuring program, which was designed to better align our assets and cost structure to the increase were $43 million in real estate sale gains, primarily from sale-leaseback transactions to enhance our financial operational flexibility on properties we continue to use in our ongoing operations. current economic environment.
Source: Item 7, 10-K 0000040987-26-000003 vs Item 7, 10-K 0000040987-25-000026
Accounting Policies 83 words changed in this paragraph; it is 41% similar to last year's version.
We formally document relationships between hedging instruments and hedged items, as well as the risk management objective and strategy for undertaking various hedge transactions. This process includes linking cash flow hedges to specific forecasted transactions or variability of cash flow to be paid. We also formally assess, both at the hedge’s inception and on an ongoing basis, whether the designated derivative and non-derivative instruments that are used in hedging transactions are highly effective in offsetting changes in the cash flows of the hedged items. When a designated instrument is determined not to be highly effective as a hedge or the underlying hedged transaction is no longer probable, hedge accounting is discontinued prospectively.
Source: Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0000040987-26-000003 vs Item 8, Note 1 – Summary of Significant Accounting Policies, 10-K 0000040987-25-000026
Legal Proceedings 44 words changed in this paragraph; it is 86% similar to last year's version.
As a result of our comprehensive legal review, including our evaluation of recent claim activity trends and our updated actuarial analysis, we increased the liability by $57 $107 million in 2024. 2025. This change in estimate resulted from new information related to our estimated number of future claims, the estimated cost of resolving claims, as well as the impacts of discount rate changes. We have 2,768 3,274 pending asbestos lawsuits as of December 31, 2024. 2025. The amount accrued for pending and future claims was $317 million as of December 31, 2025, which represented our best estimate of the liability within our calculated range of $258 million to $397 million, discounted using a discount rate of 4.18%. The amount accrued for pending and future claims was $256 million as of December 31, 2024, which represented our best estimate of the liability within our calculated range of $219 million to $313 million, discounted using a discount rate of 4.58%. The amount accrued for pending Our undiscounted product liability was $398 million and future claims was $244 $336 million as of December 31, 2023, which represented our best estimate of the liability within our calculated range of $196 million to $277 million, discounted using a discount rate of 3.88%. Our undiscounted product liability was $336 million and $308 million as of December 31, 2024 2025 and December 31, 2023, 2024, respectively.
Source: Item 3, via Note 16 – Commitments and Contingencies, 10-K 0000040987-26-000003 vs Item 3, via Note 16 – Commitments and Contingencies, 10-K 0000040987-25-000026